Logo
x

Search

Subscribe Now

update

Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19

Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19

  • March 4, 2021
Regenxbio Reports the Initiation of First Pivotal Program for RGX-314 to Treat Wet AMD

Regenxbio Reports the Initiation of First Pivotal Program for RGX-314 to Treat Wet AMD

  • January 6, 2021
Voyager Therapeutics Provides Update on NBIB-1817 (VY-AADC) Program to Treat Parkinson Disease

Voyager Therapeutics Provides Update on NBIB-1817 (VY-AADC) Program to Treat Parkinson Disease

  • December 23, 2020
Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

  • September 8, 2020
Denali and Sanofi Provide Update on its RIPK1 Program

Denali and Sanofi Provide Update on its RIPK1 Program

  • June 10, 2020
Formycon To Update on its Biosimilar Programs

Formycon To Update on its Biosimilar Programs

  • May 15, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.